about
VIP/PACAP receptor mediation of cutaneous active vasodilation during heat stress in humansVIP and PACAP effects on mouse major pelvic ganglia neurons.Augmented cystine-glutamate exchange by pituitary adenylate cyclase-activating polypeptide signaling via the VPAC1 receptor.Release of PACAP-38 in episodic cluster headache patients - an exploratory study.The density of parasympathetic axons is reduced in the exocrine pancreas of individuals recently diagnosed with type 1 diabetes.PACAP causes PAC1/VPAC2 receptor mediated hypertension and sympathoexcitation in normal and hypertensive rats.PACAP signaling exerts opposing effects on neuroprotection and neuroinflammation during disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosisCutaneous vasodilator and vasoconstrictor mechanisms in temperature regulation.PACAP Modulates Acetylcholine-Elicited Contractions at Nicotinic Neuromuscular Contacts of the Land Snail.PACAP and its receptors in migraine pathophysiology: Commentary on Walker et al., Br J Pharmacol 171: 1521-1533.PACAP expression in explant cultured mouse major pelvic ganglia.Inhibition of food intake by PACAP in the hypothalamic ventromedial nuclei is mediated by NMDA receptors.Role of VIP/PACAP in primary headaches.Molecular cloning of VIP and distribution of VIP/VPACR system in the testis of Podarcis sicula.Noncompensation in peptide/receptor gene expression and distinct behavioral phenotypes in VIP- and PACAP-deficient mice.Bone morphogenetic protein down-regulation of neuronal pituitary adenylate cyclase-activating polypeptide and reciprocal effects on vasoactive intestinal peptide expression.
P2860
Q24609073-5F782D7C-60E0-472C-8A58-7914304BE7F2Q34203896-5B3E597E-2998-4A1B-9789-32FCF079F512Q35024151-0C2C0B52-D1BE-465E-ADEA-54C938B2A722Q36090751-A8FD8624-D5CE-41CF-AAF8-69193CDCF4CFQ36409244-3377985D-13F5-4409-A84C-7501E9E2AB90Q37174587-DCF1FB45-56BF-4CC6-B084-23FFC667FF81Q37640081-EF4DA88E-9501-4218-9F6F-C5D28EFDC3FCQ38201379-EAC9495A-60B1-43B4-9063-44E81519E31BQ40772985-2A826B4C-6AA1-4E0E-9A2E-74AA3D813A49Q41295027-310E50D3-49BB-4A2D-8293-8181F7156BF1Q41763876-83732BCD-E095-49CB-AB60-E985A5BCA1C5Q42654355-8AF1C409-71C3-4E09-B7FD-49FE84D5C001Q44772355-6865ECD0-035E-4A97-9C8D-21405074CC48Q48007533-C78000FF-F6F4-4613-8BEF-AFDBDA3679CBQ48400890-6B77F271-69F3-4EDE-B348-8DCF1C3EE57DQ51998805-85BE3B4D-3968-481D-BD0A-9C72D4B2F4EA
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Neurotransmitters co-existing with VIP or PACAP.
@ast
Neurotransmitters co-existing with VIP or PACAP.
@en
type
label
Neurotransmitters co-existing with VIP or PACAP.
@ast
Neurotransmitters co-existing with VIP or PACAP.
@en
prefLabel
Neurotransmitters co-existing with VIP or PACAP.
@ast
Neurotransmitters co-existing with VIP or PACAP.
@en
P1433
P1476
Neurotransmitters co-existing with VIP or PACAP.
@en
P2093
Jan Fahrenkrug
Jens Hannibal
P304
P356
10.1016/J.PEPTIDES.2004.01.010
P577
2004-03-01T00:00:00Z